Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages

Virus Research

Volumn 92, Issue 1, 2003, Pages 83-87

  Cafruny, William A ^a   Jones, Quentin A ^a   Haven, Thomas R ^a   Zitterkopf, Nicole L ^a   Plagemann, Peter G W ^b   Rowland, Raymond R ^c  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

Dexamethasone; Lactate dehydrogenase elevating virus; Macrophages

Indexed keywords

BETA GLUCAN; DEXAMETHASONE; GLUCOCORTICOID; GLYCAN; LACTATE DEHYDROGENASE; NEUTRALIZING ANTIBODY; VIRUS ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIVIRUS; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HORMONAL REGULATION; IMMUNOGENICITY; IMMUNOREGULATION; INFECTION PREVENTION; INFECTION SENSITIVITY; LACTATE DEHYDROGENASE ELEVATING VIRUS; MACROPHAGE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; VIREMIA; VIRUS MUTANT; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES, VIRAL; ARTERIVIRUS INFECTIONS; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MACROPHAGES; MICE; NEUTRALIZATION TESTS; SPLEEN; VIRUS REPLICATION;

ARTERIVIRUS; LACTATE DEHYDROGENASE-ELEVATING VIRUS;

EID: 0037372417     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00321-0     Document Type: Article

References (27)

1. Anderson G.W., Even C., Rowland R.R.R., Palmer G.A., Harty J.T., Plagemann P.G.W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J. Neurovirol. 1:1995;244-252.
2. Anderson G.W., Palmer G.A., Rowland R.R.R., Even C., Plagemann P.G.W. Lactate dehydrogenase-elevating virus entry into central nervous system and replication in anterior horn neurons. J. Gen. Virol. 76:1995;581-592.
3. Anderson G.W., Palmer G.A., Rowland R.R.R., Even C., Plagemann P.G.W. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph nodes and testis and results in accumulation of viral RNA in germinal centers concomitant with polyclonal activation of B cells. J. Virol. 69:1995;5177-5185.
4. Broen J.B., Bradley D.S., Powell K.M., Cafruny W.A. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus. Viral. Immunol. 5:1992;133-140.
5. Cafruny W.A., Chan S.P.K., Harty J.T., Yousefi S., Kowalchyk K., McDonald D., Foreman B., Budweg G., Plagemann P.G.W. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res. 5:1986;357-375.
6. Cecchini M.G., Dominguez M.G., Mocci S., Wetterwald A., Felix R., Fleisch H., Chisholm O., Hofstetter W., Pollard J.W., Stanley E.R. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development. 120:1994;1357-1372.
7. Chen Z., Plagemann P.G.W. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological and RT-PCR assays and its removal from the tumor cells. J. Virol. Methods. 65:1997;227-236.
8. Chen Z., Li K., Rowland R.R.R., Anderson G.W., Plagemann P.G.W. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection. J. Neurovirol. 4:1998;560-568.
9. Chen Z., Li K., Rowland R.R.R., Plagemann P.G.W. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice. J. Neurovirol. 5:1999;200-208.
10. Chen Z., Li K., Plagemann P.G.W. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Virology. 266:2000;88-98.
11. Goldman R. Characteristics of the β-glucan receptor of murine macrophages. Exp. Cell Res. 174:1988;481-490.
12. Haven T.R., Rowland R.R.R., Plagemann P.G.W., Wong G.H.W., Bradley S.E., Cafruny W.A. Regulation of transplacental virus infection by developmental and immunological factors: studies with lactate dehydrogenase-elevating virus. Virus Res. 41:1996;153-161.
13. Kay J., Czop J.K. Enhancement of human monocyte β-glucan receptors by glucocorticoids. Immunology. 81:1994;96-102.
14. Li K., Chen Z., Plagemann P.G.W. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology. 242:1998;239-245.
15. Metcalf D., Begley C.G., Williamson D.J., Nice E.C., DeLamarter J., Mermod J.J., Thatcher D., Schmidt A. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol. 15:1987;1-9.
16. Metcalf D., Elliott M.J., Nicola N.A. The excess numbers of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation. J. Exp. Med. 175:1992;877-884.
17. Onyekaba C.O., Harty J.T., Even C., Hu B., Plagemann P.G.W. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Virus Res. 14:1989;297-316.
18. Parillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Ann. Rev. Pharmacol. Toxicol. 19:1979;179-201.
19. Plagemann P.G.W. Lactate dehydrogenase-elevating virus and related viruses. Fields B.N., Knipe D.M., Howley P.M. Virology. third ed:1996;1105-1120 Raven Press, New York.
20. Plagemann P.G.W. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus. Virology. 290:2001;11-20.
21. Plagemann P.G.W., Chen Z., Li K. Polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein of an arterivirus determine its neuropathogenicity, sensitivity to antibody neutralization and immunogenicity of the neutralization epitope. Curr. Top. Virol. 1:1999;27-43.
22. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science. 212:1981;1100-1109.
23. Robertson D.C., Varmus H.E. Dexamethasone induction of the intracellular RNAs of mouse mammary tumor virus. J. Virol. 40:1981;673-682.
24. Rowland R.R.R., Even C., Anderson G.W., Chen Z., Hu B., Plagemann P.G.W. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viremia of the polyclonal activation of B cells and immune complex formation. J. Gen. Virol. 75:1994;1071-1081.
25. Stueckemann J.A., Ritzi D.M., Holth M., Smith M.S., Swart W.J., Cafruny W.A., Plagemann P.G.W. Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication. J. Gen. Virol. 59:1982;245-262.
26. Taylor C.E., Weiser W.Y., Bang F.B. In vitro macrophage manifestations of cortisone-induced decrease in resistance to mouse hepatitis virus. J. Exp. Med. 153:1981;732-737.
27. Zitterkopf N.L., Haven T.R., Huela M., Bradley D.S., Cafruny W.A. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Placenta. 23:2002;438-446.